Published in J Invasive Cardiol on October 01, 1993
Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun (1972) 4.45
East pacific rise: hot springs and geophysical experiments. Science (1980) 2.94
Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect Immun (1979) 2.76
Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J Immunol (1982) 2.36
Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect Immun (1977) 2.35
Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1991) 2.31
In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J Immunol (1982) 2.19
What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis (1998) 2.18
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect Immun (1991) 1.90
Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice. Infect Immun (1980) 1.88
Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect Immun (1980) 1.77
WAG-F8(m1Ycb) rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A. J Thromb Haemost (2010) 1.69
Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol (1999) 1.69
Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans. Infect Immun (1986) 1.61
Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun (1993) 1.57
Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect Immun (1974) 1.56
Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells. J Immunol (1983) 1.52
Serovar determination and molecular taxonomic correlation in Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum: a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1993) 1.48
Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J Immunol (1985) 1.48
Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect Immun (1991) 1.48
Coronary rotational ablation: initial experience in 302 procedures. J Am Coll Cardiol (1993) 1.47
Natural cellular resistance of beige mice against Cryptococcus neoformans. J Immunol (1986) 1.44
Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells. Infect Immun (1986) 1.41
Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect Immun (1995) 1.41
Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun (1997) 1.41
Comparative study of the angiographic morphology of coronary artery lesions treated with PTCA, directional coronary atherectomy, or high-speed rotational ablation. Cathet Cardiovasc Diagn (1994) 1.41
Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infect Immun (1987) 1.39
Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun (1999) 1.35
Uncompensated care by hospitals or public insurance for the poor. Does it make a difference? N Engl J Med (1986) 1.35
Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity. Infect Immun (1985) 1.34
Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis. Infect Immun (1988) 1.33
Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis. Infect Immun (1979) 1.32
Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect Immun (1995) 1.31
In vitro binding of natural killer cells to Cryptococcus neoformans targets. Infect Immun (1985) 1.30
Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol (1992) 1.28
A child with partial deletion of a G-group autosome. Am J Dis Child (1967) 1.27
Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest (1996) 1.24
Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J (2000) 1.23
The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor. J Pharmacol Exp Ther (1999) 1.23
Antischistosomal effects of cyclosporin A. Agents Actions (1981) 1.19
Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans. Infect Immun (1989) 1.17
Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol (2000) 1.16
Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci (1995) 1.13
Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect Immun (1993) 1.11
The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med (1986) 1.09
Effect of epinephrine on cyclic adenosine 3',5'-phosphate and hexose phosphates in intestinal smooth muscle. Biochim Biophys Acta (1966) 1.08
Histological and ultrastructural changes in the blastocyst and reproductive tract of the roe deer, Capreolus capreolus, during delayed implantation. J Reprod Fertil (1973) 1.08
In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Infect Immun (1984) 1.07
Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans. Infect Immun (1991) 1.06
Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response. Infect Immun (1990) 1.05
Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med Mycol (1998) 1.04
T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection. J Infect Dis (1989) 1.04
Immunoadsorption of Cryptococcus-specific suppressor T-cell factors. Infect Immun (1986) 1.03
Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun (1994) 1.03
Percutaneous placement of Hickman catheters for prolonged venous access. Am J Surg (1982) 1.02
Intrathoracic meningoceles and neurofibromatosis. Arch Neurol (1979) 1.02
Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans. J Leukoc Biol (1990) 1.01
Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology (1997) 1.01
Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation. Infect Immun (1989) 0.99
The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice. Infect Immun (2000) 0.99
Induction of antigen-specific T suppressor cells by soluble Paracoccidioides brasiliensis antigen. Infect Immun (1988) 0.98
Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol (1992) 0.98
MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol (1997) 0.98
A virtual look at Epstein-Barr virus infection: simulation mechanism. J Theor Biol (2008) 0.97
In vitro interactions of immune lymphocytes and Cryptococcus neoformans. Infect Immun (1982) 0.95
Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor. Infect Immun (1988) 0.95
A study of childhood scalds. Burns Incl Therm Inj (1988) 0.94
Pediatric speech intelligibility test. I. Generation of test materials. Int J Pediatr Otorhinolaryngol (1980) 0.94
Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg (2000) 0.93
Prenatal diagnosis of 45,X/46,XX mosaicism in the fetus. Should the pregnancy be terminated? Prenat Diagn (1989) 0.92
Thoracic paravertebral space location. A new method using pressure measurement. Anaesthesia (1996) 0.92
Direct antimicrobial activity of T cells. Immunol Today (1995) 0.92
Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect Immun (1995) 0.91
Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans. Infect Immun (1997) 0.91
K562 cell strains differ in their response to poliovirus infection. Virology (1995) 0.91
Developmental versus conventional care: a comparison of clinical outcomes for very low birth weight infants. Can J Nurs Res (1996) 0.90
Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia (1999) 0.90
The effect of inhomogeneous sample susceptibility on measured diffusion anisotropy using NMR imaging. J Magn Reson B (1995) 0.90
CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response. Infect Immun (2000) 0.89
Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes. Infect Immun (1995) 0.89
Mammalian bites. Rational approach to management. Postgrad Med (1983) 0.89
Characterization of efferent T suppressor cells induced by Paracoccidioides brasiliensis-specific afferent T suppressor cells. Infect Immun (1988) 0.87
The N.B.T. test in systemic bacterial infection. Lancet (1973) 0.87
Mechanism of activation for Zap-70 catalytic activity. Proc Natl Acad Sci U S A (1996) 0.87
The diagnostic utility and cost-effectiveness of selective nerve root blocks in patients considered for lumbar decompression surgery: a systematic review and economic model. Health Technol Assess (2013) 0.87
Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives. J Med Chem (1992) 0.86
Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.85
Effects of Cryptococcus neoformans-specific suppressor T cells on the amplified anticryptococcal delayed-type hypersensitivity response. Infect Immun (1991) 0.85
Economic evaluation of lifestyle interventions to treat overweight or obesity in children. Int J Obes (Lond) (2012) 0.85
Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan. Infect Immun (1999) 0.84
Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response. J Immunol (1999) 0.84
Structural elements in the N-terminal half of transcription factor IIIA required for factor binding to the 5S RNA gene internal control region. Nucleic Acids Res (1991) 0.84
Safe handling practices of cytotoxic drugs: the results of a chapter survey. Oncol Nurs Forum (1994) 0.83
SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther (1997) 0.83
Immunomodulation in the mycoses. J Med Vet Mycol (1992) 0.82
REM sleep deprivation increases aggressiveness in male rats. Physiol Behav (1979) 0.82
Colour vision testing for diabetic retinopathy: a systematic review of diagnostic accuracy and economic evaluation. Health Technol Assess (2009) 0.81
Rotational ablation of balloon angioplasty failures. J Invasive Cardiol (1993) 0.81
Intracardiac repair for anomalous pulmonary venous connection of right lung to inferior vena cava. Ann Thorac Surg (1971) 0.81